MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617016781 A) filed by A Biosciences, Inc.; and The Florida State University Research Foundation on February 16, 2026, for Substituted Ergolines.
Inventors include Nichols, David; and Smith, Joel.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present disclosure relates in some aspects to substituted ergolines, such as 14-monosubstituted and 2,14-disubstituted lysergamides, and quaternized derivatives thereof. In some aspects, the disclosure relates to methods of synthesizing the compounds, compositions containing the compounds, and methods of using the compounds, including their administration to subjects. In some aspects, features of the compounds include neuromodulatory activity, for example, activation of serotonin receptors. In some further aspects, the compounds are useful as therapeutic agents, such as anti-inflammatory agents.
Disclaimer: Curated by HT Syndication.
